510(k) K213652
K213652 is an FDA 510(k) premarket notification submitted by Cresilon, Inc. for the device "Cresilon Hemostatic Gel, CHG, Cresilon Hemostatic Gel (CHG)". The FDA issued a decision of Substantially Equivalent on Jun 28, 2023. The device falls under product code QSY (Hemostatic Wound Dressing Without Thrombin Or Other Biologics), a Class U device. Cresilon, Inc. has 2 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Jun 28, 2023
- Date Received
- Nov 19, 2021
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Hemostatic Wound Dressing Without Thrombin Or Other Biologics
- Device Class
- Class U
- Review Panel
- SU
- Submission Type
- 510(k)
To temporarily control bleeding and cover external wounds.
Need the full FDA record for Cresilon, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.